A Study of CAT-1004 Biomarkers in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Assessment of Mechanistic Blood Biomarkers in Healthy Humans

In brief

This study is being conducted to assess mechanistic blood biomarkers of CAT-1004 in healthy humans.

Key facts

Study ID

NCT01670773

Run by

Catabasis Pharmaceuticals

People needed

9

Starts

2012-08-01

Expected to finish

2012-10-01

Last updated by the study team

2012-10-30

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good health as determined by medical history, vital signs, EGC, physical exam and clinical lab results
• BMI between 18 and 30 kg/m2 inclusive

You may not qualify if…

• Viral or bacterial infection within 21 days prior to randomization
• Use of prescription drugs, nonprescription drugs, herbals and dietary supplements within 7 days prior to randomization

Where it is running

• ProMedica — Brighton, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.